1-3 of 3
Gregory Malnassy
Close
Sort by
Journal Articles

WT1 Peptide Vaccine Is Able to Induce WT1-Specifc Immune Response with TCR Clonal Enrichment to Control Minimal Residual Disease in Patients with Myeloid Leukemia

Hongtao Liu, MD PhD, Yuanyuan Zha, PhD, Gregory Malnassy, Noreen Fulton, Margaret Green, Jae-Hyun Park, PhD, Yusuke Nakamura, MD, Richard A. Larson, MD, Andres M Salazar, Olatoyosi Odenike, MD, Thomas Gajewski, MD PhD, Wendy Stock, MD
Journal: Blood
Blood (2016) 128 (22): 3984.
https://doi.org/10.1182/blood.V128.22.3984.3984
Published: 2016
Journal Articles

Dose-Escalation Study of Azacitidine Followed By High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in High-Risk Acute Myeloid Leukemia (AML)

Yasmin H Karimi, MD, Nitin Jain, MD, Margaret Green, Lucy A Godley, MD, PhD, Howie Lawrence Weiner, Gregory Malnassy, Noreen Fulton, Andrew Artz, MD MS, Hongtao Liu, MDPhD, Michael J. Thirman, MD, Michael Daunov, Richard A. Larson, MD, Wendy Stock, MD, Olatoyosi Odenike, MD
Journal: Blood
Blood (2015) 126 (23): 3777.
https://doi.org/10.1182/blood.V126.23.3777.3777
Published: 2015
Journal Articles

Abl Kinase Domain Mutations Leading to Relapse of Ph+ Acute Lymphoblastic Leukemia (ALL) Occur Commonly and Can Be Detected At Initial Diagnosis: Molecular Results From CALGB 10001

Gregory Koval, B.S., Meir Wetzler, MD, Dorothy Watson, B.S., Kouros Owzar, PhD, Clara D. Bloomfield, MD, Gregory Malnassy, B.S., Dorie A. Sher, B.S., Richard A. Larson, MD, Wendy Stock, MD
Journal: Blood
Blood (2011) 118 (21): 2541.
https://doi.org/10.1182/blood.V118.21.2541.2541
Published: 2011